Neuro-Oncology News

A novel oncolytic virus gene therapy extended survival among a small cohort of patients with high-grade glioblastoma, according to study results published in Nature.

The National Academy of Medicine announced the election of 90 regular members and 10 international members.

Researchers at Salk Institute for Biological Studies have achieved promising results in early studies using an anti-CTLA-4 antibody for treatment of glioblastoma, the most common and deadliest form of brain cancer.

The FDA announced several regulatory actions.

The FDA expanded use of Temodar to include two new indications for the treatment of adults with anaplastic astrocytoma.

Results from the American Association for Cancer Research’s annual Cancer Progress Report revealed that the age-adjusted overall cancer death rate in the U.S. fell by 33% between 1991 and 2020.

Up to 25% of cancer survivors are affected by persistent symptoms of cognitive dysfunction.

A virtual reality therapy designed to ease anxiety associated with neuroimaging tests for patients with primary brain tumors appeared feasible, according to an interim analysis of a phase 2 clinical trial.

The FDA announced several regulatory actions the past few weeks.

Sameer Keole, MD, FASTRO, has been chosen president-elect of American Society for Radiation Oncology.